Department of Obstetrics and Gynecology, Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Bouali Avenue, Safaieh, 8916877391 Yazd, Iran.
Arch Gynecol Obstet. 2011 May;283(5):1159-64. doi: 10.1007/s00404-010-1828-z. Epub 2011 Jan 9.
To compare the IVF outcome of clomiphene citrate/gonadotropin/antagonist (mild protocol) and microdose GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.
159 poor responder patients were randomized and ovarian stimulation was performed with clomiphene citrate, gonadotropin and antagonist (group I) or microdose GnRH agonist flare (group II) protocols. Main outcome was clinical pregnancy rate and secondary outcomes were doses of gonadotropin administration and duration of stimulation.
There were no significant differences in age, causes of infertility, basal FSH, BMI, duration of infertility, E(2) level on the day of hCG injection in both groups. Although the cancellation, fertilization, and clinical pregnancy rates were similar in both groups, the endometrial thickness, number of retrieved oocytes, mature oocytes and implantation rate were significantly higher in mild protocol. The doses of gonadotropin administration and duration of stimulation were significantly lower in mild protocol.
We recommend mild protocol in assisted reproductive technology cycles for poor responders based on our results regarding less doses of used gonadotropin and a shorter duration of stimulation.
比较氯米酚/促性腺激素/拮抗剂(微刺激方案)与小剂量 GnRH 激动剂激发方案用于体外受精(IVF)中卵巢反应不良患者的 IVF 结局。
将 159 例卵巢反应不良患者随机分为氯米酚、促性腺激素和拮抗剂(I 组)或小剂量 GnRH 激动剂激发(II 组)方案进行卵巢刺激。主要结局为临床妊娠率,次要结局为促性腺激素用量和刺激持续时间。
两组患者的年龄、不孕原因、基础 FSH、BMI、不孕持续时间、HCG 注射日 E2 水平均无显著差异。尽管两组的取消率、受精率和临床妊娠率相似,但微刺激方案的子宫内膜厚度、获卵数、成熟卵数和着床率均显著更高。微刺激方案的促性腺激素用量和刺激持续时间显著更低。
根据我们的研究结果,即使用的促性腺激素剂量更少,刺激持续时间更短,我们推荐在辅助生殖技术周期中使用微刺激方案用于卵巢反应不良患者。